Park Avenue Securities LLC Argenx Se Transaction History
Park Avenue Securities LLC
- $8.9 Billion
- Q3 2024
A detailed history of Park Avenue Securities LLC transactions in Argenx Se stock. As of the latest transaction made, Park Avenue Securities LLC holds 1,211 shares of ARGX stock, worth $655,187. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,211
Previous 1,324
8.53%
Holding current value
$655,187
Previous $569,000
15.29%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding ARGX
# of Institutions
373Shares Held
31.6MCall Options Held
303KPut Options Held
429K-
Price T Rowe Associates Inc Baltimore, MD5.6MShares$3.03 Billion0.29% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$1.9 Billion2.39% of portfolio
-
Janus Henderson Group PLC London, X02.47MShares$1.34 Billion0.58% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.92MShares$1.04 Billion0.52% of portfolio
-
Capital World Investors Los Angeles, CA1.51MShares$818 Million0.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $29.9B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...